The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).
Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.
Harnessing the immune system’s natural ability to fight cancer is at the heart of research from the Department of Immunotechnology and Alligator Bioscience. The team is developing a new type of antibody able to stimulate immune activity and enhance the body’s response against cancer. The findings may help pave the way for more effective immunotherapies with broader patient benefit.
Prof. Malin Lindestedt, head of the Department, and Petter Ellmark, head of translational research at Alligator Bioscience, are leading the industrial PhD project of Hampus Andersson. The research project has been highlighted in Framtidens Forskning where you can read details about the bispecific antibodies and their targets.
Immunsystemet programmeras om i kampen mot cancer (in Swedish, Framtidens Forskning's website)